Eliasson B, Liakopoulos V, Franzén S, Näslund I, Svensson A-M, Ottosson J et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol 2015; 3: 847–854.
Tailleux A, Rouskas K, Pattou F, Staels B. Bariatric surgery, lipoprotein metabolism and cardiovascular risk. Curr Opin Lipidol 2015; 22: 317–324.
Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 2014; 260: 893–898; discussion 898–899.
Osto E, Doytcheva P, Corteville C, Bueter M, Dörig C, Stivala S et al. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1. Circulation 2015; 131: 871–881.
Dirksen C, Bojsen-Møller KN, Jørgensen NB, Jacobsen SH, Kristiansen VB, Naver LS et al. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass. Diabetologia 2013; 56: 2679–2687.
Laferrère B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709–1716.
Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg 2013; 148: 563–569.
Osto M, Abegg K, Bueter M, le Roux CW, Cani PD, Lutz TA. Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine. Physiol Behav 2013; 119: 92–96.
Sweeney TE, Morton JM. Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol 2014; 28: 727–740.
Penney NC, Kinross JM, Newton RC, Purkayastha S. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: A systematic review. Int J Obes 20052015; 17: 1565–1574.
Tremaroli V, Karlsson F, Werling M, Ståhlman M, Kovatcheva-Datchary P, Olbers T et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 2015; 22: 228–238.
Bhutta HY, Rajpal N, White W, Freudenberg JM, Liu Y, Way J et al. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats. PloS One 2015; 10: e0122273.
Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care 2013; 36: 1859–1864.
Patti M-E, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obes Silver Spring Md 2009; 17: 1671–1677.
Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Käkelä P, Pääkkönen M et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1473–1480.
Werling M, Vincent RP, Cross GF, Marschall H-U, Fändriks L, Lönroth H et al. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol 2013; 48: 1257–1264.
Sachdev S, Wang Q, Billington C, Connett J, Ahmed L, Inabnet W et al. FGF 19 and bile acids increase following Roux-en-Y Gastric bypass but not after medical management in patients with type 2 diabetes. Obes Surg 2016; 26: 957–965.
Dutia R, Embrey M, O’Brien S, Haeusler RA, Agénor KK, Homel P et al. Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes 2005 2015; 39: 806–813.
Steinert RE, Peterli R, Keller S, Meyer-Gerspach AC, Drewe J, Peters T et al. Bile acids and gut peptide secretion after bariatric surgery: A 1-year prospective randomized pilot trial. Obesity 2013; 21: E660–E668.
Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes 2013; 37: 1553–1559.
Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012; 153: 3613–3619.
Albaugh VL, Flynn CR, Cai S, Xiao Y, Tamboli RA, Abumrad NN. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids. J Clin Endocrinol Metab 2015; 100: E1225–E1233.
Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 2009; 58: 1400–1407.
Jansen PLM, van Werven J, Aarts E, Berends F, Janssen I, Stoker J et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Dig Dis Basel Switz 2011; 29: 48–51.
Mazuy C, Helleboid A, Staels B, Lefebvre P. Nuclear bile acid signaling through the farnesoid X receptor. Cell Mol Life Sci 2014; 72: 1631–1650.
Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009; 89: 147–191.
Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509: 183–188.
Verhaeghe R, Zerrweck C, Hubert T, Tréchot B, Gmyr V, D’Herbomez M et al. Gastric bypass increases postprandial insulin and GLP-1 in nonobese minipigs. Eur Surg Res 2014; 52: 41–49.
Spinelli V, Lalloyer F, Baud G, Osto E, Kouach M, Daoudi M et al. Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. Int J Obes 2016; 40: 1260–1267.
Broeders EPM, Nascimento EBM, Havekes B, Brans B, Roumans KHM, Tailleux A et al. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab 2015; 28: 418–426.
Ferrannini E, Camastra S, Astiarraga B, Nannipieri M, Castro-Perez J, Xie D et al. Increased bile acid synthesis and deconjugation after biliopancreatic diversion. Diabetes 2015; 26: 3377–3385.